A nurse is collecting data from a client who has a major depressive disorder and a new prescription for bupropion. Which of the following findings should the nurse identify as a contraindication for this medication?

Introduction: Bupropion is an atypical antidepressant that functions by inhibiting the reuptake of norepinephrine and dopamine. It significantly lowers the seizure threshold in a dose-dependent manner, making it a high-risk pharmacologic agent for individuals with pre-existing neurological instability or metabolic conditions that predispose them to abnormal electrical activity in the brain. A. An allergy to peanuts is not a contraindication for bupropion. While some medications use peanut oil as a vehicle in soft gel capsules (such as certain formulations of progesterone), bupropion tablets do not typically contain peanut-derived components. The nurse should always verify specific manufacturer ingredients, but this is not a standard contraindication. B. Smoking cigarettes is not a contraindication; in fact, bupropion is FDA-approved under the brand name Zyban as a primary pharmacological aid for smoking cessation. It helps reduce nicotine cravings and withdrawal symptoms by modulating the dopamine reward pathways, making it a preferred choice for depressed clients who smoke. C. Asthma is a chronic inflammatory airway disease that does not interact with the mechanism of action of bupropion. Bupropion does not possess significant anticholinergic effects or beta-blocking properties that would exacerbate bronchospasm, allowing it to be safely administered to clients with various obstructive or restrictive pulmonary conditions. D. A seizure disorder is a primary contraindication for bupropion. Due to its potential to induce generalized tonic-clonic seizures, it is strictly avoided in clients with epilepsy or those with a history of head trauma. It is also contraindicated in clients with eating disorders (bulimia or anorexia) due to associated electrolyte imbalances that further increase seizure risk.